Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Gross Profit: 2010-2018

Historic Gross Profit for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Sep 2018 value amounting to -$3.2 million.

  • EyePoint Pharmaceuticals' Gross Profit fell 920.78% to -$3.2 million in Q3 2018 from the same period last year, while for Sep 2018 it was -$1.4 million, marking a year-over-year decrease of 118.53%. This contributed to the annual value of $1.4 million for FY2018, which is 80.78% down from last year.
  • Latest data reveals that EyePoint Pharmaceuticals reported Gross Profit of -$3.2 million as of Q3 2018, which was down 541.96% from $715,000 recorded in Q2 2018.
  • EyePoint Pharmaceuticals' 5-year Gross Profit high stood at $25.3 million for Q3 2014, and its period low was -$3.2 million during Q3 2018.
  • For the 3-year period, EyePoint Pharmaceuticals' Gross Profit averaged around $648,636, with its median value being $385,000 (2017).
  • In the last 5 years, EyePoint Pharmaceuticals' Gross Profit spiked by 4,139.03% in 2014 and then crashed by 920.78% in 2018.
  • EyePoint Pharmaceuticals' Gross Profit (Quarterly) stood at $521,000 in 2014, then increased by 0.96% to $526,000 in 2015, then spiked by 1,035.17% to $6.0 million in 2016, then slumped by 98.33% to $100,000 in 2017, then plummeted by 920.78% to -$3.2 million in 2018.
  • Its Gross Profit was -$3.2 million in Q3 2018, compared to $715,000 in Q2 2018 and $928,000 in Q1 2018.